The impact of music therapy on agitation in elderly patients with dementia: A systematic review and meta-analysis
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Music therapy (MT) significantly reduces agitation in elderly dementia patients, offering a promising non-pharmacological intervention. This approach is effective across various settings, including homes without professional nursing support.
Area Of Science
- Gerontology
- Neuroscience
- Psychiatry
Background
- Agitation affects 50-80% of elderly dementia patients, posing significant challenges for caregivers and healthcare systems.
- Current pharmacological treatments for agitation are limited, highlighting the need for alternative interventions.
- Non-pharmacological music therapy (MT) has emerged as a promising approach to manage agitation.
Purpose Of The Study
- To evaluate the efficacy of music therapy (MT) in alleviating agitation in elderly individuals with dementia.
- To synthesize evidence from existing studies on MT's impact on dementia-related agitation.
Main Methods
- A comprehensive literature search was conducted across multiple databases.
- Included 14 studies (10 randomized controlled trials, 4 pre-post trials) with a total of 847 participants.
- A meta-analysis was performed to assess the overall effect of MT on agitation.
Main Results
- Meta-analysis revealed that MT significantly reduced agitation in dementia patients, with a moderate effect size (d = 0.42).
- Subgroup analyses confirmed consistent positive findings.
- Low heterogeneity and negligible publication bias suggest robust results.
Conclusions
- Music therapy is an effective intervention for mitigating agitation in dementia patients.
- The generalizability of MT is high, applicable in resource-constrained settings and home environments.
- Evidence supports the integration of MT into standard dementia care protocols.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...